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. The most extensively studied protease in human breast cancer is cathepsin D, which was first identified as a 52 kDa oestrogen-dependent glycoprotein in MCF-7 cells (Rochefort et al., 1987 (Spyratos et al., 1989 (Spyratos et al., , 1992 Thorpe et al., 1989; Tandon et al., 1990; Granata et al., 1991; Namer et al., 1991; Duffy et al., 1992; Kute et al., 1992; Pujol et al., 1993) . These Sections from routinely fixed (over 24 h in neutral buffered formalin) paraffin-embedded blocks were cut on Vectabondtreated slides (Vector Laboratories, Buringame, CA, USA).
The slides were dewaxed, rehydrated and stained using a standard avidin-biotin-enhanced inmunoperoxidas technique (Vectastain Elite kit, Vector Laboratories, Burlingame, CA, USA). The mouse MAb ICIl (IgGI) was used at a concentration of 50 ng ml-' (incubation overnight at +4C).
The production and specificity of the ICI1 antibody have been described dsewhere (Isola et al., 1993 tested together with these factors using Cox's stepwise analysis, only axillary nodal status (relative risk 4.2, 95% confidence interval 2.4-7.1), the primary tumour size (2.2, 1.6-3.1), histological grade (1.6, 1.2-2.2) and histological type (1.6, 1.02-2.5) had independent prognostic value. Similarly, stromal cell cathepsin D expression did not have independent prognostic value when tested among patents with node-negative disease, node-positive disease, those with ductal breast cancer or post-menopausal women, but it had prognostic value among premenopausal women (2.8, 1.1-7.1) together with axillary nodal status (4.6, 1.8-11.8), primary tumour size (2.2, 1.3-3.9) and histological type of cancer (3.3, 1.4-7.9).
Expression of stromal cell cathepsin D was associated with poor prognosis and several established adverse prognostic factors in breast cancer, such as a high mitotic count, poor histological grade of differentiation and positive axillary nodal status, whereas tumour cell cathepsin D expression was associated with none of these factors. Until recently, tumour cell stroma has been considered to play a passive role in the growing cancer, but now a considerable body of evidence has accumulated suggesting a more active participation of stromal cells in the process of invasion. Several proteases are active in stromal cells of malignant tumours. In human adenocarcinoma of the colon, urokinasetype plasminogen activator (uPA), which specifically activates the conversion of plasminogen to the broad substrate spectrum protease plasmin, can be found by immunohistochemistry in the fibroblast-like cells in tumour stroma, but not in the malignant epithelial cells (Grondahl-Hansen et al., 1991) . Similarly, its mRNA is expressed by fibroblast-like stromal cells adjacent to the invasive tumour nodules (Pyke et al., 1991) . Interstitial collagenase immunoreactivity is also located in stromal cells (Hewitt et al., 1991) , as well as mRNAs for 72 kDa type IV collagenase (Poulson et al., 1992) and 92 kDa collagenase (Dano et al., 1993 (Rochefort, 1992 (Vignon et al., 1986) , and it may promote cell growth by binding to IGF-II receptor (Mathieu et al., 1990) . In line with these findings, we found strong cathepsin D expression of stromal cells to be associated with a high mitotic count and a high S-phase fraction size. A high stromal cell cathepsin D level has been found to be associated with a high S-phase fraction in another study (Isola et al., 1993) 
